O	O	0	10	Resistance	Resistance	B-NP	NN	O	10	SUB	O
O	O	11	13	to	to	B-PP	TO	O	1	NMOD	O
O	O	14	19	tumor	tumor	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	20	28	necrosis	necrosis	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	29	35	factor	factor	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	36	43	induced	induced	I-NP	JJ	O	7	NMOD	O
O	O	44	53	apoptosis	apoptosis	I-NP	NN	O	2	PMOD	O
O	O	54	56	in	in	B-ADVP	FW	O	9	AMOD	O
O	O	57	62	vitro	vitro	I-ADVP	FW	O	7	NMOD	O
O	O	63	73	correlates	correlate	B-VP	VBZ	O	0	ROOT	O
O	O	74	78	with	with	B-PP	IN	O	10	VMOD	O
O	O	79	83	high	high	B-NP	JJ	O	14	NMOD	O
O	O	84	94	metastatic	metastatic	I-NP	JJ	O	14	NMOD	O
O	O	95	103	capacity	capacity	I-NP	NN	O	11	PMOD	O
O	O	104	106	of	of	B-PP	IN	O	14	NMOD	O
O	O	107	112	cells	cell	B-NP	NNS	O	15	PMOD	O
O	O	113	115	in	in	B-ADVP	FW	O	16	NMOD	O
O	O	116	120	vivo	vivo	I-ADVP	FW	O	17	AMOD	O
O	O	120	121	.	.	O	.	O	10	P	O

O	O	123	126	TNF	TNF	B-NP	NN	B-protein	2	SUB	B-protein
O	O	127	129	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	130	133	one	one	B-NP	CD	O	2	PRD	O
O	O	134	136	of	of	B-PP	IN	O	3	NMOD	O
O	O	137	140	the	the	B-NP	DT	O	6	NMOD	O
O	O	141	150	cytokines	cytokine	I-NP	NNS	B-protein	4	PMOD	B-protein
O	O	151	159	secreted	secrete	B-VP	VBN	O	6	NMOD	O
O	O	160	162	by	by	B-PP	IN	O	7	VMOD	O
O	O	163	166	the	the	B-NP	DT	O	10	NMOD	O
O	O	167	172	cells	cell	I-NP	NNS	O	8	PMOD	O
O	O	173	175	of	of	B-PP	IN	O	10	NMOD	O
O	O	176	179	the	the	B-NP	DT	O	14	NMOD	O
O	O	180	186	immune	immune	I-NP	JJ	O	14	NMOD	O
O	O	187	193	system	system	I-NP	NN	O	11	PMOD	O
O	O	193	194	.	.	O	.	O	2	P	O

O	O	195	198	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	199	203	data	datum	I-NP	NNS	O	3	SUB	O
O	O	204	215	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	216	220	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	221	226	those	those	B-NP	DT	O	7	NMOD	O
O	O	227	231	cell	cell	I-NP	NN	B-cell_line	7	NMOD	B-cell_line
O	O	232	237	lines	line	I-NP	NNS	I-cell_line	16	SUB	I-cell_line
O	O	238	245	lacking	lack	B-VP	VBG	O	7	NMOD	O
O	O	246	256	capability	capability	B-NP	NN	O	8	OBJ	O
O	O	257	259	to	to	B-VP	TO	O	11	VMOD	O
O	O	260	264	form	form	I-VP	VB	O	9	NMOD	O
O	O	265	275	metastatic	metastatic	B-NP	JJ	O	13	NMOD	O
O	O	276	282	tumors	tumor	I-NP	NNS	O	11	OBJ	O
O	O	283	285	in	in	B-ADVP	FW	O	11	VMOD	O
O	O	286	290	vivo	vivo	I-ADVP	FW	O	14	AMOD	O
O	O	291	294	are	be	B-VP	VBP	O	4	SBAR	O
O	O	295	306	susceptible	susceptible	B-ADJP	JJ	O	16	PRD	O
O	O	307	309	to	to	B-PP	TO	O	17	AMOD	O
O	O	310	313	TNF	TNF	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	314	321	induced	induced	I-NP	JJ	O	19	AMOD	O
O	O	322	331	apoptosis	apoptosis	I-NP	NN	O	18	PMOD	O
O	O	332	334	in	in	B-ADVP	FW	O	23	AMOD	O
O	O	335	340	vitro	vitro	I-ADVP	FW	O	17	AMOD	O
O	O	340	341	.	.	O	.	O	3	P	O

O	O	342	349	However	However	B-ADVP	RB	O	9	VMOD	O
O	O	349	350	,	,	O	,	O	9	P	O
O	O	351	355	cell	cell	B-NP	NN	B-cell_line	4	NMOD	B-cell_line
O	O	356	361	lines	line	I-NP	NNS	I-cell_line	9	SUB	I-cell_line
O	O	362	366	with	with	B-PP	IN	O	4	NMOD	O
O	O	367	371	high	high	B-NP	JJ	O	8	NMOD	O
O	O	372	382	metastatic	metastatic	I-NP	JJ	O	8	NMOD	O
O	O	383	392	potential	potential	I-NP	NN	O	5	PMOD	O
O	O	393	396	are	be	B-VP	VBP	O	0	ROOT	O
O	O	397	406	resistant	resistant	B-ADJP	JJ	O	9	PRD	O
O	O	407	409	to	to	B-PP	TO	O	10	AMOD	O
O	O	410	413	TNF	TNF	B-NP	NN	B-protein	11	PMOD	B-protein
O	O	414	416	in	in	B-ADVP	FW	O	14	AMOD	O
O	O	417	422	vitro	vitro	I-ADVP	FW	O	10	AMOD	O
O	O	422	423	.	.	O	.	O	9	P	O

O	O	424	435	Furthermore	Furthermore	B-ADVP	RB	O	7	VMOD	O
O	O	435	436	,	,	O	,	O	7	P	O
O	O	437	440	the	the	B-NP	DT	O	6	NMOD	O
O	O	441	445	same	same	I-NP	JJ	O	6	NMOD	O
O	O	446	450	cell	cell	I-NP	NN	B-cell_line	6	NMOD	B-cell_line
O	O	451	456	lines	line	I-NP	NNS	I-cell_line	7	SUB	I-cell_line
O	O	457	461	were	be	B-VP	VBD	O	0	ROOT	O
O	O	462	471	resistant	resistant	B-ADJP	JJ	O	7	PRD	O
O	O	472	474	to	to	B-PP	TO	O	8	AMOD	O
O	O	475	484	cytolytic	cytolytic	B-NP	JJ	O	11	NMOD	O
O	O	485	491	action	action	I-NP	NN	O	9	PMOD	O
O	O	492	494	of	of	B-PP	IN	O	11	NMOD	O
O	O	495	500	other	other	B-NP	JJ	O	15	NMOD	O
O	O	501	510	cytotoxic	cytotoxic	I-NP	JJ	B-protein	15	NMOD	B-protein
O	O	511	519	proteins	protein	I-NP	NNS	I-protein	12	PMOD	I-protein
O	O	520	528	secreted	secrete	B-VP	VBN	O	15	NMOD	O
O	O	529	531	by	by	B-PP	IN	O	16	VMOD	O
O	O	532	535	LAK	LAK	B-NP	NN	B-cell_line	19	NMOD	B-cell_line
O	O	536	541	cells	cell	I-NP	NNS	I-cell_line	17	PMOD	I-cell_line
O	O	541	542	.	.	O	.	O	7	P	O

O	O	543	546	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	547	551	data	datum	I-NP	NNS	O	3	SUB	O
O	O	552	558	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	559	563	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	564	567	TNF	TNF	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	568	578	resistance	resistance	I-NP	NN	O	9	SUB	O
O	O	579	581	in	in	B-ADVP	FW	O	8	AMOD	O
O	O	582	587	vitro	vitro	I-ADVP	FW	O	6	NMOD	O
O	O	588	598	correlates	correlate	B-VP	VBZ	O	4	SBAR	O
O	O	599	603	with	with	B-PP	IN	O	9	VMOD	O
O	O	604	607	the	the	B-NP	DT	O	13	NMOD	O
O	O	608	617	increased	increase	I-NP	VBN	O	13	NMOD	O
O	O	618	623	level	level	I-NP	NN	O	10	PMOD	O
O	O	624	626	of	of	B-PP	IN	O	13	NMOD	O
O	O	627	640	transcription	transcription	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	641	647	factor	factor	I-NP	NN	I-protein	19	NMOD	I-protein
T1	B-Entity	648	650	NF	NF	I-NP	NN	B-protein	19	NMOD	B-protein
T1	I-Entity	650	651	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T1	I-Entity	651	657	kappaB	kappaB	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	657	658	.	.	O	.	O	3	P	O

O	O	659	663	This	This	B-NP	DT	O	2	NMOD	O
O	O	664	671	finding	finding	I-NP	NN	O	3	SUB	O
O	O	672	675	may	may	B-VP	MD	O	0	ROOT	O
O	O	676	683	provide	provide	I-VP	VB	O	3	VC	O
O	O	684	685	a	a	B-NP	DT	O	6	NMOD	O
O	O	686	690	tool	tool	I-NP	NN	O	14	NMOD	O
O	O	691	693	to	to	B-VP	TO	O	8	VMOD	O
O	O	694	701	improve	improve	I-VP	VB	O	6	NMOD	O
O	O	702	709	current	current	B-NP	JJ	O	10	NMOD	O
O	O	710	719	protocols	protocol	I-NP	NNS	O	8	OBJ	O
O	O	720	722	of	of	B-PP	IN	O	10	NMOD	O
O	O	723	736	immunotherapy	immunotherapy	B-NP	NN	O	11	PMOD	O
O	O	737	740	and	and	I-NP	CC	O	14	NMOD	O
O	O	741	749	insights	insight	I-NP	NNS	O	4	OBJ	O
O	O	750	752	to	to	B-PP	TO	O	14	NMOD	O
O	O	753	756	how	how	B-ADVP	WRB	O	15	PMOD	O
O	O	757	762	tumor	tumor	B-NP	NN	B-cell_type	18	NMOD	B-cell_type
O	O	763	768	cells	cell	I-NP	NNS	I-cell_type	19	SUB	I-cell_type
O	O	769	772	are	be	B-VP	VBP	O	16	SBAR	O
O	O	773	775	or	or	O	CC	O	19	VMOD	O
O	O	776	779	are	be	B-VP	VBP	O	19	VMOD	O
O	O	780	783	not	not	I-VP	RB	O	21	VMOD	O
O	O	784	790	killed	kill	I-VP	VBN	O	19	VMOD	O
O	O	791	793	by	by	B-PP	IN	O	23	VMOD	O
O	O	794	797	LAK	LAK	B-NP	NN	B-cell_line	26	NMOD	B-cell_line
O	O	798	803	cells	cell	I-NP	NNS	I-cell_line	24	PMOD	I-cell_line
O	O	803	804	.	.	O	.	O	3	P	O
